Hantz Financial Services’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Sell |
1,047
-24,709
| -96% | -$5.4M | ﹤0.01% | 601 |
|
|
2025
Q1 | $5.77M | Sell |
25,756
-1,061
| -4% | -$238K | 0.1% | 192 |
|
|
2024
Q4 | $8.78M | Buy |
26,817
+490
| +2% | +$161K | 0.15% | 145 |
|
|
2024
Q3 | $7.9M | Sell |
26,327
-2,739
| -9% | -$822K | 0.14% | 173 |
|
|
2024
Q2 | $9.57M | Sell |
29,066
-1,287
| -4% | -$424K | 0.18% | 139 |
|
|
2024
Q1 | $12M | Sell |
30,353
-2,160
| -7% | -$855K | 0.23% | 114 |
|
|
2023
Q4 | $11.4M | Sell |
32,513
-1,240
| -4% | -$437K | 0.25% | 118 |
|
|
2023
Q3 | $12.7M | Sell |
33,753
-20
| -0.1% | -$7.51K | 0.32% | 88 |
|
|
2023
Q2 | $12.9M | Buy |
33,773
+851
| +3% | +$325K | 0.32% | 85 |
|
|
2023
Q1 | $11.4M | Sell |
32,922
-1,403
| -4% | -$486K | 0.31% | 88 |
|
|
2022
Q4 | $8.08M | Sell |
34,325
-2,473
| -7% | -$582K | 0.24% | 130 |
|
|
2022
Q3 | $9.06M | Buy |
36,798
+1,161
| +3% | +$286K | 0.31% | 97 |
|
|
2022
Q2 | $10.8M | Buy |
35,637
+524
| +1% | +$158K | 0.36% | 80 |
|
|
2022
Q1 | $14.4M | Buy |
35,113
+2,136
| +6% | +$877K | 0.43% | 59 |
|
|
2021
Q4 | $15.5M | Buy |
32,977
+2,082
| +7% | +$977K | 0.45% | 60 |
|
|
2021
Q3 | $13.1M | Buy |
30,895
+3,766
| +14% | +$1.6M | 0.43% | 66 |
|
|
2021
Q2 | $9.74M | Buy |
27,129
+1,372
| +5% | +$493K | 0.36% | 75 |
|
|
2021
Q1 | $7.26M | Buy |
25,757
+1,393
| +6% | +$393K | 0.3% | 92 |
|
|
2020
Q4 | $6.9M | Buy |
24,364
+641
| +3% | +$182K | 0.31% | 93 |
|
|
2020
Q3 | $6.52M | Buy |
23,723
+541
| +2% | +$149K | 0.33% | 80 |
|
|
2020
Q2 | $5.27M | Buy |
+23,182
| New | +$5.27M | 0.29% | 101 |
|